Latest News about BIIB
Recent news which mentions BIIB
More Specificity is What the Doctor Ordered
December 14, 2021
From Benzinga
‘Grandma and grandpa aren’t going to figure this one out.’ Prescription-drug savings vanish in the Medicare shuffle
December 10, 2021
From MarketWatch
Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021
December 09, 2021
From Benzinga
The Daily Biotech Pulse: Valneva Strikes Deal To Supply COVID Vaccine to Bahrain, TherapeuticsMD & Amneal Settle Patent Lawsuit, Reata Awaits Adcom
December 08, 2021
From Benzinga
Early Clinical Data Suggest This New Lotion Could Offer Best-In-Class Eczema Treatment and Infection Prevention, According to Hoth Therapeutics
December 07, 2021
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021
December 06, 2021
From Benzinga
Should You Blame Biogen for Medicare Part B Premium Hikes?
December 03, 2021
Tickers
BIIB
From Motley Fool
Sage Therapeutics - Biogen Share One Year Zuranolone 50mg Data In Depression Patients
December 01, 2021
From Benzinga
From Benzinga
Biogen Loses Bid To Revive Tecfidera Drug Patent: Bloomberg
November 30, 2021
From Benzinga
Could Roche Put a Crinkle in Biogen's Alzheimer's Drug Launch?
November 28, 2021
From Motley Fool
2 Moonshot Biotechs with 10x Potential
November 22, 2021
From InvestorPlace
The Week Ahead In Biotech (Nov. 21-Nov. 27): Takeda, Aadi, Fennec FDA Decisions, Earnings In The Spotlight In Holiday-Shortened Week
November 21, 2021
From Benzinga
1 Cancer Stock on Buyout Watch in 2022
November 21, 2021
From Motley Fool
Ocugen Stock: Bull vs. Bear
November 20, 2021
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For November 19, 2021
November 19, 2021
From Benzinga
From Benzinga
3 Biotech Stocks That Have More Than Tripled so far This Year
November 18, 2021
From Motley Fool
European Regulator Votes Down Biogen's Alzheimer's Drug
November 17, 2021
Tickers
BIIB
From Benzinga
Jim Cramer Likes This Stock Over Cassava Sciences And Biogen
November 17, 2021
From Benzinga
Could Eli Lilly Leapfrog Biogen in This Market?
November 17, 2021
From Motley Fool
The Daily Biotech Pulse: Kezar Jumps On Data, Biogen R&D Chief To Retire, Molecular Partners Wilts On COVID Trial Disappointment
November 16, 2021
From Benzinga
President Biden Nominates Robert Califf As New FDA Commissioner: Report
November 12, 2021
From Benzinga
Why Are Biogen Shares Gaining Today?
November 12, 2021
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.